Streamlining the supply chain: insights on raw material sourcing and quality by design

“...maintaining quality by design is especially difficult in CGT because we have variable starting material.

Abi Pinchbeck, Editor, BioInsights, speaks to Lara Silverman, Founder and Principal Consultant, LIS BioConsulting, discussing the critical role of supply chain management in early-stage cell and gene therapy companies, including raw and starting material sourcing strategies. They cover the importance of QbD in advanced therapies, regulatory expectations surrounding the supply chain, and how evolving technologies can help drive down manufacturing costs.

Please enter your email to access content Read now